Infinity Pharmaceuticals Inc (INFIQ)
0.00
USD |
OTCM |
May 17, 16:00
Infinity Pharmaceuticals Net Income (Quarterly): -9.956M for June 30, 2023
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | -9.956M |
| March 31, 2023 | -11.04M |
| December 31, 2022 | -9.23M |
| September 30, 2022 | -10.72M |
| June 30, 2022 | -11.99M |
| March 31, 2022 | -12.44M |
| December 31, 2021 | -11.65M |
| September 30, 2021 | -10.71M |
| June 30, 2021 | -11.27M |
| March 31, 2021 | -11.63M |
| December 31, 2020 | -10.60M |
| September 30, 2020 | -9.534M |
| June 30, 2020 | -9.473M |
| March 31, 2020 | -10.89M |
| December 31, 2019 | -11.38M |
| September 30, 2019 | -11.42M |
| June 30, 2019 | -10.51M |
| March 31, 2019 | -13.74M |
| December 31, 2018 | -8.22M |
| September 30, 2018 | 13.38M |
| June 30, 2018 | -6.963M |
| March 31, 2018 | -9.451M |
| December 31, 2017 | -7.296M |
| September 30, 2017 | -7.104M |
| June 30, 2017 | -16.95M |
| Date | Value |
|---|---|
| March 31, 2017 | -10.48M |
| December 31, 2016 | -22.93M |
| September 30, 2016 | -19.50M |
| June 30, 2016 | 52.99M |
| March 31, 2016 | -40.66M |
| December 31, 2015 | -39.19M |
| September 30, 2015 | 42.54M |
| June 30, 2015 | -38.43M |
| March 31, 2015 | -93.30M |
| December 31, 2014 | -40.34M |
| September 30, 2014 | 103.22M |
| June 30, 2014 | -38.02M |
| March 31, 2014 | -42.27M |
| December 31, 2013 | -32.92M |
| September 30, 2013 | -33.94M |
| June 30, 2013 | -32.59M |
| March 31, 2013 | -27.33M |
| December 31, 2012 | -46.98M |
| September 30, 2012 | 18.40M |
| June 30, 2012 | -14.66M |
| March 31, 2012 | -10.72M |
| December 31, 2011 | -14.06M |
| September 30, 2011 | -11.94M |
| June 30, 2011 | -11.73M |
| March 31, 2011 | -2.306M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-12.44M
Minimum
Mar 2022
-9.23M
Maximum
Dec 2022
-10.85M
Average
-10.89M
Median
Mar 2020
Net Income (Quarterly) Benchmarks
| Athersys Inc | -3.771M |
| Merck & Co Inc | 4.762B |
| MEI Pharma Inc | -9.127M |
| Humanigen Inc | -4.182M |
| Bristol-Myers Squibb Co | -11.91B |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 0.583M |
| Total Expenses (Quarterly) | 10.70M |
| EPS Diluted (Quarterly) | -0.11 |
| Gross Profit Margin (Quarterly) | 39.62% |
| Profit Margin (Quarterly) | -1.71K% |